Home › Compare › SHPHF vs GBDC

SHPHF vs GBDC: Dividend Comparison 2026

SHPHF yields 1.45% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.83M in total portfolio value
10 years
SHPHF
SHPHF
● Live price
1.45%
Share price
$0.19
Annual div
$0.00
5Y div CAGR
12.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.8K
Annual income
$550.34
Full SHPHF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — SHPHF vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHPHFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHPHF + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SHPHF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHPHF
Annual income on $10K today (after 15% tax)
$123.06/yr
After 10yr DRIP, annual income (after tax)
$467.79/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $13,982,655.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHPHF + GBDC for your $10,000?

SHPHF: 50%GBDC: 50%
100% GBDC50/50100% SHPHF
Portfolio after 10yr
$10.44M
Annual income
$8,225,642.09/yr
Blended yield
78.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

SHPHF
No analyst data
Altman Z
1.9
Piotroski
5/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHPHF buys
0
GBDC buys
0
No recent congressional trades found for SHPHF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHPHFGBDC
Forward yield1.45%11.86% ✓
Annual dividend / share$0.00$1.50 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR12.4%51.1% ✓
Portfolio after 10y$23.8K ✓$20.85M
Annual income after 10y$550.34$16,450,733.83 ✓
Total dividends collected$3.2K$20.43M ✓
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: SHPHF vs GBDC ($10,000, DRIP)

YearSHPHF PortfolioSHPHF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$10,863$162.72$12,492$1,791.70$1.6K → GBDC
2$11,809$185.68$16,527$3,160.58$4.7K → GBDC
3$12,847$212.04$23,588$5,904.90$10.7K → GBDC
4$13,989$242.33$37,141$11,901.65$23.2K → GBDC
5$15,246$277.19$66,205$26,463.38$51.0K → GBDC
6$16,630$317.33$137,452$66,612.65$120.8K → GBDC
7$18,158$363.61$342,372$195,298.53$324.2K → GBDC
8$19,846$417.05$1,053,292$686,954.33$1.03M → GBDC
9$21,714$478.83$4,111,439$2,984,416.95$4.09M → GBDC
10$23,784$550.34$20,849,974$16,450,733.83$20.83M → GBDC

SHPHF vs GBDC: Complete Analysis 2026

SHPHF — Stock

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.

Full SHPHF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this SHPHF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHPHF vs SCHDSHPHF vs JEPISHPHF vs OSHPHF vs KOSHPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.